Contrast Enhanced Magnetic Resonance Imaging as a Diagnostic Tool to Assess Bladder Permeability and Associated Colon Cross Talk: Preclinical Studies in a Rat Model
Abstract
Purpose:
Interstitial cystitis/painful bladder syndrome is a devastating disease associated with multiple symptoms. It is usually diagnosed based on pain, urgency and frequency in the absence of other known causes. To our knowledge there is no diagnostic test to date.
Materials and Methods:
In a model of rats intravesically exposed to protamine sulfate we performed in vivo diagnostic contrast enhanced magnetic resonance imaging with intravesical administration of Gd-diethylenetriamine pentaacetic acid contrast medium via a catheter to visualize increased bladder urothelium permeability. Gd-diethylenetriamine pentaacetic acid was administered intravenously to visualize secondary tissue effects in the colon.
Results:
Bladder urothelium and colon mucosa were assessed 24 hours after bladder protamine sulfate exposure. Enhanced contrast magnetic resonance imaging established bladder urothelium leakage of Gd-diethylenetriamine pentaacetic acid according to the change in magnetic resonance imaging signal intensity in rats exposed to protamine sulfate vs controls (mean ± SD 399.7% ± 68.7% vs 39.2% ± 12.2%, p <0.0001) as well as colon related uptake of contrast agent (mean 65.2% ± 17.1% vs 20.8% ± 9.8%, p <0.01) after bladder protamine sulfate exposure. The kinetics of Gd-diethylenetriamine pentaacetic acid uptake and excretion were also assessed during 20 minutes of bladder and 30 minutes of colon exposure with increased signal intensity at 7 and 12 minutes, respectively.
Conclusions:
These preliminary studies indicate that contrast enhanced magnetic resonance imaging can be used to monitor primary bladder urothelium loss of permeability and secondary enhanced contrast medium in the colon mucosa. It can be considered a potential clinical diagnostic method for interstitial cystitis/painful bladder syndrome that involves loss of the permeability barrier. It can also be used to assess visceral organ cross talk.
References
- 1 : Prevalence of symptoms of bladder pain syndrome/interstitial cystitis among adult females in the United States. J Urol2011; 186: 540. Link, Google Scholar
- 2 : Gynecological disorders in bladder pain syndrome/interstitial cystitis patients. Int J Urol2014; 21: 85. Google Scholar
- 3 : Challenges and current evidence on the management of bladder pain syndrome. Neurourol Urodyn2014; 33: 1193. Google Scholar
- 4 : Interstitial cystitis/bladder pain syndrome: diagnosis and management. Int Urogynecol J2013; 24: 1243. Google Scholar
- 5 : The role of the bladder surface in interstitial cystitis/painful bladder syndrome. Can J Urol2007; 14: 3599. Google Scholar
- 6 : Urine is necessary to provoke bladder inflammation in protamine sulfate induced urothelial injury. J Urol2008; 180: 1527. Link, Google Scholar
- 7 : Painful bladder syndrome: an update and review of current management strategies. Curr Urol Rep2014; 15: 384. Google Scholar
- 8 : Tracer kinetic analysis of dynamic contrast-enhanced MRI and CT bladder cancer data: a preliminary comparison to assess the magnitude of water exchange effects. Magn Reson Med2010; 64: 595. Google Scholar
- 9 : Characterization of texture features of bladder carcinoma and the bladder wall on MRI: initial experience. Acad Radiol2013; 20: 930. Google Scholar
- 10 : Value of MRI in local staging of bladder cancer. Urol J2013; 10: 866. Google Scholar
- 11 : Clinical value of T2-weighted imaging combined with diffusion-weighted imaging in preoperative T staging of urinary bladder cancer: a large-scale, multiobserver prospective study on 3.0-T MRI. Acad Radiol2013; 20: 939. Google Scholar
- 12 : Bladder wall thickness mapping for magnetic resonance cystography. Phys Med Biol2013; 58: 5173. Google Scholar
- 13 : Impact of the radiotherapy technique on the correlation between dose-volume histograms of the bladder wall defined on MRI imaging and dose-volume/surface histograms in prostate cancer patients. Phys Med Biol2013; 58: N115. Google Scholar
- 14 : A new method for cytodestruction of bladder epithelium using protamine sulfate and urea. J Urol1994; 152: 1025. Link, Google Scholar
- 15 : Protamine sulfate induced bladder injury protects from distention induced bladder pain. J Urol2013; 189: 343. Link, Google Scholar
- 16 : Abnormal expression of differentiation related proteins and proteoglycan core proteins in the urothelium of patients with interstitial cystitis. J Urol2008; 179: 764. Link, Google Scholar
- 17 : Evidence for overlap between urological and nonurological unexplained clinical conditions. J Urol2013; 189: S66. Google Scholar
- 18 : Hyperexcitability of convergent colon and bladder dorsal root ganglion neurons after colonic inflammation: mechanism for pelvic organ cross-talk. Neurogastroenterol Motil2006; 18: 936. Google Scholar
- 19 : Evidence for the role of mast cells in colon-bladder cross organ sensitization. Auton Neurosci2013; 173: 6. Google Scholar
- 20 : Practical considerations in T1 mapping of prostate for dynamic contrast enhancement pharmacokinetic analyses. Magn Reson Imaging2012; 30: 1224. Google Scholar
- 21 : Cystitis, co-morbid disorders and associated epithelial dysfunction. Neurourol Urodyn2011; 30: 668. Google Scholar
- 22 : A mouse model for interstitial cystitis/painful bladder syndrome based on APF inhibition of bladder epithelial repair: a pilot study. BMC Urol2012; 12: 17. Google Scholar
- 23 : Decreased in vitro proliferation of bladder epithelial cells from patients with interstitial cystitis. Urology2003; 61: 1278. Google Scholar
- 24 : Bladder defense molecules, urothelial differentiation, urinary biomarkers, and interstitial cystitis. Urology2007; 69: 17. Google Scholar
- 25 : Up-regulation of P2X3 receptor during stretch of bladder urothelial cells from patients with interstitial cystitis. J Urol2004; 17: 448. Google Scholar
- 26 : miR-199a-5p regulates urothelial permeability and may play a role in bladder pain syndrome. Am J Pathol2013; 182: 431. Google Scholar
- 27 : The distribution and function of chondroitin sulfate and other sulfated glycosaminoglycans in the human bladder and their contribution to the protective bladder barrier. J Urol2013; 189: 336. Link, Google Scholar
- 28 : Intravesical chondroitin sulfate inhibits recruitment of inflammatory cells in an acute acid damage “leaky bladder” model of cystitis. Urology2012; 79: 483.e13. Google Scholar
- 29 : Interstitial cystitis: bladder pain and beyond. Expert Opin Pharmacother2008; 9: 2979. Google Scholar
